Increasing the refractive index available for optical and nanophotonic systems opens new vistas for design, for applications ranging from broadband metalenses to ultrathin photovoltaics to high-quality-factor resonators. In this work, fundamental limits to the refractive index of any material are derived, given only the underlying electron density and either the maximum allowable dispersion or the minimum bandwidth of interest. In the realm of small to modest dispersion, the bounds are closely approached and not surpassed by a wide range of natural materials, showing that nature has already nearly reached a Pareto frontier for refractive index and dispersion. Conversely, for narrow-bandwidth applications, nature does not provide the highly dispersive, high-index materials that the bounds suggest should be possible. The theory of composites to identify metal-based metamaterials that can exhibit small losses and sizeable increases in refractive index over the current best materials is used. Moreover, if the "elusive lossless metal" can be synthesized, it is shown that it would enable arbitrarily high refractive index in the high-dispersion regime, nearly achieving the bounds even at refractive indices of 100 and beyond at optical frequencies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/adma.202103946 | DOI Listing |
Curr Microbiol
January 2025
Molecular Biology Laboratory, Department of Microbiology, Science Campus, Alagappa University, Karaikudi, Tamil Nadu, 630003, India.
Antimicrobial resistance (AMR) is an escalating global health concern that results in approximately 700,000 deaths annually owing to drug-resistant infections. It compromises the effectiveness of conventional antibiotics, as well as fundamental medical procedures, such as surgery and cancer treatment. Phytochemicals, natural plant constituents, and biogenic nanoparticles synthesized through biological processes are pharmacological alternatives for supplementing or replacing traditional antibiotics.
View Article and Find Full Text PDFBMC Psychiatry
January 2025
Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
Background: The neurasthenia-depression controversy has lasted for several decades. It is challenging to solve the argument by symptoms alone for syndrome-based disease classification. Our aim was to identify objective electroencephalography (EEG) measures that can differentiate neurasthenia from major depressive disorder (MDD).
View Article and Find Full Text PDFBMC Womens Health
January 2025
Department of Obstetrics and Gynecology Nursing, Gulhane Faculty of Nursing, University of Health Sciences Turkey, Ankara, Turkey.
Background: Women are disproportionately affected by disasters due to their vulnerability and limited access to resources. The purpose of this study is to investigate the health concerns and experiences of women who relocated to a different city following the February 2023 earthquake in Turkey.
Methods: Data was collected using a constructivist qualitative research design.
Sci Rep
January 2025
Research and Development, Aesculap AG, Tuttlingen, Germany.
In clinical movement biomechanics, kinematic measurements are collected to characterise the motion of articulating joints and investigate how different factors influence movement patterns. Representative time-series signals are calculated to encapsulate (complex and multidimensional) kinematic datasets succinctly. Exacerbated by numerous difficulties to consistently define joint coordinate frames, the influence of local frame orientation and position on the characteristics of the resultant kinematic signals has been previously proven to be a major limitation.
View Article and Find Full Text PDFJ Immunother Cancer
January 2025
Sonata Therapeutics Inc, Watertown, Massachusetts, USA
Cancer immunotherapy-including immune checkpoint inhibition (ICI) and adoptive cell therapy (ACT)-has become a standard, potentially curative treatment for a subset of advanced solid and liquid tumors. However, most patients with cancer do not benefit from the rapidly evolving improvements in the understanding of principal mechanisms determining cancer immune responsiveness (CIR); including patient-specific genetically determined and acquired factors, as well as intrinsic cancer cell biology. Though CIR is multifactorial, fundamental concepts are emerging that should be considered for the design of novel therapeutic strategies and related clinical studies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!